Related Experiment Videos
Coronary artery stenting in patients with severe left ventricular dysfunction
Farhan Aslam1, James C Blankenship
1Department of Internal Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA.
The Journal of Invasive Cardiology
|December 6, 2005
Summary
Percutaneous coronary intervention (PCI) stenting is safe for patients with severe left ventricular dysfunction. This procedure improved symptoms and survival in patients with reduced ejection fraction.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Severe left ventricular dysfunction poses significant risks.
- Percutaneous coronary intervention (PCI) is a common treatment for coronary artery disease.
Purpose of the Study:
- To evaluate the effectiveness and safety of coronary stenting in patients with severely reduced left ventricular ejection fraction (LVEF).
Main Methods:
- Analysis of 149 consecutive patients with LVEF ≤ 40% undergoing coronary stenting.
- Assessment of angiographic and clinical success rates.
- Evaluation of patient survival and symptom status at a minimum 6-month follow-up (mean 24 months).
Main Results:
- Successful stent placement (angiographic and clinical) in all patients.
- High survival rate at follow-up: 130 patients (89%) were alive.
- Significant symptom improvement: 124 patients (85%) reported fewer symptoms post-PCI.
Conclusions:
- Percutaneous coronary intervention (PCI) is a safe and effective treatment option for patients with severe left ventricular dysfunction.
- Coronary stenting in this patient group leads to improved long-term symptom relief and survival.